ArticleNature communications2026
Modular Scalable Synthetic Gene Circuits for Complex Functions Within Minimal Computational Layers in Human Cells.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Engineering mammalian cells to execute complex genetic programs remains a significant challenge in synthetic biology. Synthetic gene circuits typically implement sophisticated programs through cascaded computational layers. However, these architectures require numerous orthogonal parts, increase genetic payload, and deplete cellular resources, thereby limiting functionality and scalability. We present a modular design framework for engineering scalable gene circuits that execute complex functions within fewer computational layers. The platform integrates orthogonal trans-splicing-based AND gates, native-synthetic hybrid promoters for tunable regulation, and synthetic microRNAs that implement inhibitory logic. Using this approach, we engineer complex circuits, including a three-input combinatorial logic gate, a half adder, a full adder, and a dynamic 3-to-1 multiplexer with a dedicated Selector Overload Status output, generated only when both selector inputs are activated. By minimizing the number of computational layers while maintaining functionality, this strategy addresses scalability barriers in gene circuit engineering and expands applicability for biomedicine, biotechnology, and fundamental biology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.